Search

everythinglearnresearchcommunity

for

Search:↓

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Severe hair loss links to metabolic issues in older men with psoriasis.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Myrtle has various health benefits and potential for medicine development.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Oral testosterone therapy raises heart risk more than other methods.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Using topical minoxidil for baldness can cause heart problems, especially in those with heart disease.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.